Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative pain therapy comparison after knee endoprosthesis implantation
2019-001725-27Phase 4Terminated
- Sponsor
- Martin Luther University Halle-Wittenberg
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxycodone, ropivacaine and sufentanil in postoperative pain (3 arms), sponsored by Martin Luther University Halle-Wittenberg. Primary endpoints: Postoperative pain on postoperative day 3 at rest and Postoperative pain on postoperative day 3 under strain. Started May 2019; status: terminated.
02
Drugs
oxycodoneropivacainesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2019-001725-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001725-27.